ARS Pharmaceuticals, Inc. SPRY
Set alert
3.38 USD -0.28 -7.65%
At close · Oct 30
3.38 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
3.34 Day range 3.79
3.34 52-week range 13.15
- YTD
- -70.99%
- 1 year
- -60.79%
- Open
- 3.62
- Prev close
- 3.66
- Mkt cap
- 336.13M
- Vol
- 1.76M
- Avg vol
- 1.65M
- EPS
- -2.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.34
- High
- 3.79
- Forward P/E
- -11.01
- Beta
- 0.83
- Short ratio
- 13.70
- Inst. own
- 95.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2026
- 50-d avg
- 8.64
- 200-d avg
- 9.38
- 1y target
- 28.80
MAX chart
Events in this range
- Oct 8, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Jan 13, 2025Rating: Leerink Partners · Outperform → Outperform
- Jan 14, 2025Rating: Raymond James · Strong Buy → Strong Buy
- Mar 7, 2025Rating: Scotiabank · — → Sector Outperform
- May 14, 2025Earnings: -0.35; estimate -0.35; surprise 0%
- Aug 13, 2025Earnings: -0.46; estimate -0.41; surprise -12.2%
- Sep 4, 2025Rating: Roth Capital · — → Buy
- Nov 10, 2025Earnings: -0.52; estimate -0.45; surprise -15.56%
- Mar 9, 2026Earnings: -0.42; estimate -0.42; surprise 0%
- May 15, 2026Earnings: -0.61; estimate -0.53; surprise -15.09%
- May 28, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Aug 13, 2026Earnings: —; estimate -0.47655; surprise —%
Signals (83)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Apr 7, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| RSI: Overbought | Nov 4, 2024 | 1 year ago |
| RSI: Overbought | Oct 14, 2024 | 2 years ago |
| RSI: Overbought | Aug 12, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 8, 2024 | 2 years ago |
| RSI: Overbought | Jul 8, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | May 20, 2024 | 2 years ago |
| SMA: Bearish | May 6, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| RSI: Overbought | Mar 25, 2024 | 2 years ago |
| RSI: Overbought | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Jan 1, 2024 | 2 years ago |
| MACD: Buy Signal | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 18, 2023 | 3 years ago |
| SMA: Bullish | Sep 4, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| SMA: Bearish | Jun 5, 2023 | 3 years ago |
| SMA: Bearish | May 29, 2023 | 3 years ago |
| SMA: Bullish | May 8, 2023 | 3 years ago |
| SMA: Bullish | May 8, 2023 | 3 years ago |
| SMA: Bearish | Mar 27, 2023 | 3 years ago |
| SMA: Bearish | Mar 20, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 20, 2023 | 3 years ago |
| SMA: Bullish | Feb 6, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 6, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 23, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| RSI: Overbought | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | May 16, 2022 | 4 years ago |
| MACD: Buy Signal | Dec 6, 2021 | 4 years ago |
| RSI: Oversold | Sep 13, 2021 | 5 years ago |
| SMA: Bearish | Jul 26, 2021 | 5 years ago |
| SMA: Bullish | Jun 7, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| SMA: Bullish | Mar 8, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
Financial health
Altman Z-Score
-3.08 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -6.7×
FY 2018 5y median -9.5× FY 2025
P/S 13.6×
FY 2018 5y median 34.9× FY 2025
P/B 10.1×
FY 2018 5y median 2.3× FY 2025
P/FCF -6.7×
FY 2018 5y median -8.5× FY 2025
EV/EBITDA -7.2×
FY 2018 5y median -7.1× FY 2025
EV/Sales 14.3×
FY 2018 5y median 25.7× FY 2025
FCF Yield -14.9%
FY 2018 5y median -11.4% FY 2025
Profitability
Gross Margin 75.8%
FY 2018 5y median 76.9% FY 2025
Operating Margin -212.9%
FY 2018 5y median -353.3% FY 2025
Net Margin -203.3%
FY 2018 5y median -367.7% FY 2025
ROE -149.9%
FY 2018 5y median -12.7% FY 2025
ROIC -62.2%
FY 2018 5y median -29.2% FY 2025
ROA -52.3%
FY 2018 5y median -23.3% FY 2025
Growth (YoY)
Revenue -5.5%
FY 2018 FY 2025
Operating Income -5720.6%
FY 2018 FY 2025
EPS (diluted) -2327.9%
FY 2018 FY 2025
Free Cash Flow -1418.5%
FY 2018 FY 2025
Financial Health
Current Ratio 7.3×
FY 2018 5y median 14.3× FY 2025
Quick Ratio 7.1×
FY 2018 5y median 14.0× FY 2025
Debt / Equity 0.8×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -0.3×
FY 2018 5y median 1.3× FY 2025
Interest Coverage -69.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31